CRH Dividend Received from Consumer Healthcare JV decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $9.00M to $0.00. Over 4 years (FY 2021 to FY 2025), Dividend Received from Consumer Healthcare JV shows an upward trend with a 11.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher dividends indicate strong performance of the underlying joint venture, contributing positively to the bank's non-interest income.
Cash inflows representing the bank's share of profits distributed from a joint venture or equity-method investment. This...
Specific to companies with equity-method investments; peers report this as income from unconsolidated subsidiaries.
pfe_dividend_received_from_consumer_healthcare_jv| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $8.00M | $8.00M | $8.00M | $9.00M | $9.00M | $9.00M | $9.00M | $8.00M | $4.00M | $11.00M | $21.00M | $6.00M | $9.00M | $7.00M | $22.00M | $9.00M | $4.00M | $10.00M | $27.00M | $0.00 |
| QoQ Change | — | +0.0% | +0.0% | +12.5% | +0.0% | +0.0% | +0.0% | -11.1% | -50.0% | +175.0% | +90.9% | -71.4% | +50.0% | -22.2% | +214.3% | -59.1% | -55.6% | +150.0% | +170.0% | -100.0% |
| YoY Change | — | — | — | — | +12.5% | +12.5% | +12.5% | -11.1% | -55.6% | +22.2% | +133.3% | -25.0% | +125.0% | -36.4% | +4.8% | +50.0% | -55.6% | +42.9% | +22.7% | -100.0% |